Fundraising Fox
🦊/Companies
Sign in

AlphaRose Therapeutics

1 known investors

Find your way into AlphaRose Therapeutics

AlphaRose develops genetic technologies and treatments for children with rare genetic diseases, aiming to make and commercialize such medicines at scale. It targets patients underserved by the current healthcare model for rare genetic conditions.

BiotechHealthtech

Investors · 1

Advent Life SciencesLondon

In the news

Austin toddler battles ultra-rare genetic disease; family seeks funding for life-saving treatment | kens5.comkens5.com · Sep 20262-year-old needs $3M treatment for rare genetic disorder affecting fewer than 50 children | weareiowa.comweareiowa.com · Sep 2026Casey McPherson: Why 95% of Rare Genetic Diseases Have Zero FDA-Approved Treatments, and What AlphaRose Is Doing About It | C-Suite Briefcsuitebrief.com · Jul 2026AlphaRose Therapeutics on StartEngine 2025 - Kingscrowdkingscrowd.com · Jan 2025

Frequently asked questions

What does AlphaRose Therapeutics do?
AlphaRose develops genetic technologies and treatments for children with rare genetic diseases, aiming to make and commercialize such medicines at scale. It targets patients underserved by the current healthcare model for rare genetic conditions.
Who are AlphaRose Therapeutics's investors?
AlphaRose Therapeutics's investors include Advent Life Sciences.